Thermo Fisher Scientific
TMO
2,616 hedge funds and large institutions have $178B invested in Thermo Fisher Scientific in 2024 Q4 according to their latest regulatory filings, with 299 funds opening new positions, 887 increasing their positions, 1,086 reducing their positions, and 201 closing their positions.
49% more first-time investments, than exits
New positions opened: 299 | Existing positions closed: 201
2% more funds holding
Funds holding: 2,568 → 2,616 (+48)
0.02% more ownership
Funds ownership: 88.52% → 88.54% (+0.02%)
15% less capital invested
Capital invested by funds: $208B → $178B (-$30.2B)
18% less repeat investments, than reductions
Existing positions increased: 887 | Existing positions reduced: 1,086
21% less call options, than puts
Call options by funds: $1.14B | Put options by funds: $1.44B
37% less funds holding in top 10
Funds holding in top 10: 116 → 73 (-43)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$1.27B |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$788M |
| 3 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$352M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$288M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$254M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$909M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$847M |
| 3 |
IAIM
International Assets Investment Management
Orlando,
Florida
|
-$778M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$605M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$515M |
TMO Hedge Fund Activity: Q4 2024 in Review
2,616 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q4 2024, worth a combined $178B — down 15% from $208B a quarter earlier.
Buyers outnumbered sellers: 299 funds opened new TMO positions and 201 closed out — a net gain of 98 holders — while 887 added to existing stakes and 1,086 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $1.27B. The largest seller was Bank of America, cutting an estimated $909M.
- 2,616 institutional investors held Thermo Fisher Scientific (TMO) as of Q4 2024, up from 2,568 in Q3 2024.
- Funds reported $178B of Thermo Fisher Scientific stock for Q4 2024, down 15% quarter-over-quarter.
- 299 funds opened new Thermo Fisher Scientific positions in Q4 2024 and 201 closed out, a net change of +98 holders.
- The largest Thermo Fisher Scientific buyer in Q4 2024 was JP Morgan Chase, an estimated $1.27B added.
- The largest Thermo Fisher Scientific seller in Q4 2024 was Bank of America, an estimated $909M sold.
Based on aggregated 13F filings for Q4 2024.